“What Happened?” Exploring the Complexities of Clinical Inertia in the Treatment of People with Type 2 Diabetes

Authors

Nisha Hodge, MPHc, BA, Thomas Jefferson UniversityFollow
Marianna LaNoue, PhD, MS, Thomas Jefferson UniversityFollow

Document Type

Presentation

Publication Date

3-23-2018

Comments

Presentation: 4:48

Abstract

The diabetes epidemic in the US affects over 29 million individuals every day. Type 2 diabetes accounts for 95% of those cases. Each year approximately $245 billion is spent on caring for individuals with diabetes. Yet, 33-49% of patients with diabetes do not meet the target for glycemic control. There are many reasons that can be cited as to the cause for the lack of glycemic control in almost half of patients with diabetes however one possible explanation is the phenomenon of clinical inertia. Clinical inertia in the treatment of type 2 diabetes is the failure of a healthcare provider to escalate pharmacotherapy when glycemic control (HbA1c

Recommended Citation

Hodge, MPHc, BA, Nisha and LaNoue, PhD, MS, Marianna, "“What Happened?” Exploring the Complexities of Clinical Inertia in the Treatment of People with Type 2 Diabetes" (2018). Master of Public Health Capstone Presentations. Presentation 248.
https://jdc.jefferson.edu/mphcapstone_presentation/248

Language

English